- Home
- STRO vs SIFY Comparison
STRO vs SIFY Comparison
Compare STRO & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SIFY
- Stock Information
- Founded
- STRO 2003
- SIFY 1995
- Country
- STRO United States
- SIFY India
- Employees
- STRO N/A
- SIFY N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SIFY Computer Software: Programming Data Processing
- Sector
- STRO Health Care
- SIFY Technology
- Exchange
- STRO Nasdaq
- SIFY Nasdaq
- Market Cap
- STRO 292.6M
- SIFY 249.9M
- IPO Year
- STRO 2018
- SIFY 1999
- Fundamental
- Price
- STRO $2.80
- SIFY $3.46
- Analyst Decision
- STRO Strong Buy
- SIFY
- Analyst Count
- STRO 7
- SIFY 0
- Target Price
- STRO $12.14
- SIFY N/A
- AVG Volume (30 Days)
- STRO 888.5K
- SIFY 92.7K
- Earning Date
- STRO 11-13-2024
- SIFY 01-16-2025
- Dividend Yield
- STRO N/A
- SIFY N/A
- EPS Growth
- STRO N/A
- SIFY N/A
- EPS
- STRO N/A
- SIFY N/A
- Revenue
- STRO $160,955,000.00
- SIFY $443,027,157.00
- Revenue This Year
- STRO N/A
- SIFY N/A
- Revenue Next Year
- STRO N/A
- SIFY $12.52
- P/E Ratio
- STRO N/A
- SIFY $64.22
- Revenue Growth
- STRO 230.90
- SIFY 5.85
- 52 Week Low
- STRO $2.45
- SIFY $1.80
- 52 Week High
- STRO $6.13
- SIFY $12.30
- Technical
- Relative Strength Index (RSI)
- STRO 39.12
- SIFY 58.30
- Support Level
- STRO $2.55
- SIFY $3.40
- Resistance Level
- STRO $2.76
- SIFY $3.62
- Average True Range (ATR)
- STRO 0.27
- SIFY 0.19
- MACD
- STRO -0.05
- SIFY 0.04
- Stochastic Oscillator
- STRO 18.51
- SIFY 83.78
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.